Glaxo Wellcome, the biggest pharmaceutical company in the world, has
named Jennie Younger as its new director of investor relations as part
of a rejig of its financial communications.
Younger, who has been head of investor relations at British Gas for the
last three-and-a-half years, joins the company this autumn with
responsibility for managing relations with its institutional
shareholders and financial analysts around the world.
Based in London with two other support staff, she will report to Glaxo
Wellcome’s finance director John Coombe. Her role will not include
managing relations with the financial media, which continues to be
handled by the firm’s public affairs department under its corporate
communications director Geoffrey Potter.
Younger’s appointment ends an extensive trawl by management headhunters
for suitable candidates for the job among agency and in-house staff
which began earlier this year (PR Week 31 May).
The search itself was prompted by the retirement later this year of
Penny Burnett, Glaxo Wellcome’s current investor relations director
based in New York. Although Burnett will be replaced in the US, the new
postholder there will report to Younger in the UK.
Younger had been in line to become head of investor relations at Transco
after the demerger of British Gas next year.
Shares in Glaxo Wellcome rose this week after a trial showed that
treatments including one of its HIV drugs stalled the progression of
Aids among patients.